Who
Francesco Galimi
CMO& Head of Development
Company insider
Files Form 4 as: CMO& Head of Development, Genenta Science S.p.A; SVP & Chief Medical Officer, Adicet Bio.
In numbers
- Trades disclosed
- 48
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $328K
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 15 Sep 2020
- Last trade
- 30 Mar 2026
- Last filed
- 1 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Mar 2026filed 1 Apr 2026 | GNTA Genenta Science S.p.Aoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 30 Mar 2026filed 1 Apr 2026 | GNTA Genenta Science S.p.Aoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 5 Jun 2024filed 7 Jun 2024 | ACET Adicet Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —375,077 at $0.00 | filing |
| 24 Jan 2024filed 26 Jan 2024 | ACET Adicet Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —288,134 at $0.00 | filing |
| 24 Jan 2024filed 26 Jan 2024 | ACET Adicet BioBiotechnology | SEC FORM 4 Code F | $12K4,957 at $2.40 | filing |
| 24 Jan 2024filed 26 Jan 2024 | ACET Adicet BioBiotechnology | SEC FORM 4 Code A | —26,300 at $0.00 | filing |
| 2 Oct 2023filed 3 Oct 2023 | ACET Adicet BioBiotechnology | SEC FORM 4 Code F | $11K8,093 at $1.37 | filing |
| 14 Aug 2023filed 16 Aug 2023 | ACET Adicet Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —113,652 at $0.00 | filing |
| 14 Aug 2023filed 16 Aug 2023 | ACET Adicet Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —113,652 at $0.00 | filing |
| 14 Aug 2023filed 16 Aug 2023 | ACET Adicet Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —77,269 at $0.00 | filing |
| 14 Aug 2023filed 16 Aug 2023 | ACET Adicet Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —77,269 at $0.00 | filing |
| 14 Aug 2023filed 16 Aug 2023 | ACET Adicet Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —73,964 at $0.00 | filing |
| 14 Aug 2023filed 16 Aug 2023 | ACET Adicet Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —73,964 at $0.00 | filing |
| 14 Aug 2023filed 16 Aug 2023 | ACET Adicet Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —26,625 at $0.00 | filing |
| 14 Aug 2023filed 16 Aug 2023 | ACET Adicet Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —26,625 at $0.00 | filing |
| 14 Aug 2023filed 16 Aug 2023 | ACET Adicet Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —125,000 at $0.00 | filing |
| 14 Aug 2023filed 16 Aug 2023 | ACET Adicet Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 14 Aug 2023filed 16 Aug 2023 | ACET Adicet Biooption or derivative · Biotechnology | SEC FORM 4 Code D | —117,200 at $0.00 | filing |
| 14 Aug 2023filed 16 Aug 2023 | ACET Adicet Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —117,200 at $0.00 | filing |
| 24 Jan 2023filed 26 Jan 2023 | ACET Adicet Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —117,200 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.